Why did ALTHE.PA stock fall sharply today?

ALTHE.PA stock declined **18.18%** mostly on heavier selling and sector weakness rather than a fresh company announcement. Volume rose to **95,516** versus average **78,004**, suggesting liquidity-driven pressure among small-cap medical-device names.

What are key valuation metrics for ALTHE.PA stock?

Theraclion shows EPS **-€0.11**, PE negative **-4.09**, market cap **€21,223,440.00**, price/sales around **17.36**, and cash per share **€0.07**. These metrics reflect loss-making status with modest liquidity.

What is the short-term outlook and price target for ALTHE.PA stock?

Short-term the stock is oversold with support at **€0.45** and resistance **€0.51-€0.60**. Meyka AI's forecast model projects a yearly **€1.02** price, implying **+126.25%** versus **€0.45**; forecasts are model projections, not guarantees.

EU Stocks

ALTHE.PA Theraclion SA (EURONEXT) -18.18% 11 Mar 2026: oversold, watch support

ByDanny Kontos March 12, 2026March 12, 2026

The ALTHE.PA stock fell 18.18% to €0.45 at market close on 11 Mar 2026, making it one of EURONEXT’s top losers today. Volume rose to 95,516 shares versus an average of 78,004, signalling heavier selling pressure in the Healthcare — Medical Devices segment. The drop left the share below its 50-day average of €0.63 and 200-day average of €0.60, with technical indicators now in oversold territory. Meyka AI’s real-time tools flagged the move and we examine fundamentals, technicals, and short-term price targets for investors.